is glp 1 a hormone or peptide Glucagon-like peptide-1 Physiological role of glucagon-like peptide-1

EPS: ~$23.50 Forward P/E: ~42 (premium justified by growth) PEG Ratio: ~0.9 (attractive given growth rate) Long-Term Track Record Performance: 52-Week Range: $623.78 - $999.92 1-Year Return: +20-25% (volatile but trending up) Market Leadership: Approaching $1 trillion valuation Dividend Profile: Current Yield: ~0.6% (modest but growing) Annual Dividend: $6.00 per share Growth Rate: Consistently increasing ~15% CAGR The dividend is small now, but management prioritizes reinvestment in R&D while rewarding long-term shareholders with steady increases

for their ability to cause dramatic weight loss over time

Looking forward to continuing to follow your amazing work

Practice Point: Consider holding the last dose of GLP-1 receptor agonists prior to elective surgery to reduce aspiration risk

3 Follow with a moisturizer to seal in hydration

Due to KPV being mostly experimental there is no established therapeutic dosage